PECULIARITIES OF PRODUCTION OF SECRETORY LEUCOCYTE PROTEINASE INHIBITOR IN CHILDREN WITH ACUTE OR CHRONIC PYELONEPHRITIS
Abstract
Aims. The goal of the work is to determine the role and significance of the level of the secretory leucocyte proteinase inhibitor (SLPI) in children’s blood and urine with acute (A) and chronic (Ch) pyelonephritis (PN).
Materials and methods. In 26 patients with ChPN in the stage of remission and in 12patients with ChPN at the stage of exacerbation, and in 19 patients with APN were used to study the level ofSLPI in children’s blood and urine by the enzyme–linked immunosorbent assay and corresponding test–systems.
Results. It was found that statistically significant difference between the concentration ofSLPI in children with APN and ChPN, and, accordingly, in the acute stage and remission of ChPN not found (p<0.05). There is a correlation between the concentration ofSLPI and the number of lymphocytes in the peripheral blood (p<0,05) in patients with APN (rK=0,605) and with ChPN at the stage of exacerbation (rK=536). Correlations between the level ofSLPI, C–reactive protein and erythrocyte sedimentation rate and the numbers of neutrophils is not installed (p>0,05).
Conclusions. The results indicated the participation ofSLPI into the pathogenesis of APN and ChPN at the stage of exacerbation.
Downloads
References
Лях Ю. М. Основы компьютерной биостатистики : анализ информации в биологии, медицине и фармации статистическим пакетом MedStat / Ю. М. Лях, В. Г. Гурьянов, В. Н. Хоменко, О. А. Панченко / Донецк : 2006, 211 с.
Маянский А Н. Цитокины и медиаторные функции уроэпителия в воспалительных реакциях мочевыводящей системы / А. Н. Маянский // Цитокины и воспаление. – 2003. – № 3. – С. 15–18.
Основи нефрології / за редакцією М. О. Колесника // К.: Тов “Доктор–Медіа”, 2010. – 380 с.
Тареев Е. М. Клиническая нефрология. – М.: Медицина, 1983. – 880 с.
ХаитовР. М. Значение функциональной активности толл–подобных рецепторов и других рецепторов врожденной иммуной системы в физиологии почек // Р. М. Хаитов, Б. В. Пинегин, М. В. Пащенков // Рос. Физиол. Журн. им. И. М.Сеченова – 2007. – Т. 91, №. 5. – С. 505–520.
Черешнев В. А. Иммунология воспаления: роль цитокиинов / В. А. Черешнев, Е. Ю. Гусев // Медицинская Иммунология. – 2001. – Т.3, № 3. – С. 361–368.
Чикилева И. О. Двойственная роль толл–подобных рецепторов в регуляции противоопухолевого иммунитета / И. О. Чикилева, А. В. Караулов, Н. Ю. Анисимова, М. В. Киселевский // Иммунология. – 2010. – № 1. – С. 52–55.
Doumas S. Anti–Inflammatory and Antimicrobial Roles of Secretory Leukocyte Protease Inhibitor / S. Doumas, A. Kolokotronis, P. Stefanopoulos // Infection and Immunity. – 2005. – №.3. – Р. 1271– 1274.
Greene C. M. Secretory leucoprotease inhibitor impairs toll–like receptor 2– and 4–mediated responses in monocytic cells / C. M. Greene, N. G. Mcelvaney, S. J. O,Neill // Infection а^ mmunity. – 2004 (June). – Р. 3684–3689.
Ohlsson S. Novel distribution of the secretory leucocyte proteinase inhibitor in kidney / S. Ohlsson,
I. Ljungkrantz, K. Ohlsson [et al.] // Mediators оf Inflammation. – 2001. – Vol. 10. – P. 347–350.
Sallenave J. M. Secretory leukocyte protease inhibitor and elafin/trappin–2. Versatile mucosal antimicrobials and regulators of immunity / J. M. Sallenave // American journal of respiratory cell and molecular biology. – 2010. – Vol. 42, №.6. – Р. 635–643.
Subramaniyam D. Secretory leukocyte protease inhibitor inhibits neutrophil apoptosis / D. Subramaniyam, С. Hollander, U. Westin [et al.] // Respirology. – 2011. – Vol. 16. – №2. – Р. 300–307.
Williams S. E. SLPI and elafin : one glove, many fingers / S. E. Williams, T. I. Brown, A. Roghanian, J. M. Sallenave // Clinical Science. – 2006. – Vol. 110. – P. 21–35.
Xiaoyuan Wang. Endotoxins : structure, function and recognition / Xiaoyuan Wang , P. J. Quinn // Springer science+business media b.v., 2010. – 415 p.
